Skip to main content
Abnova logo

Abnova — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Open in API
Filings indexed 1,483 across all filing types
Latest filing 2013-05-08 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
102年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a short disclosure from a listed company (亞諾法) providing information about fund lending balances and endorsement guarantees for the current and previous month, including limits and cumulative amounts. It contains no financial statements, no management discussion, no voting results, no legal proceedings, no executive changes, and no detailed financial data. The length is only 610 characters, which is very short and typical of a regulatory or compliance disclosure. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a regulatory disclosure about financial guarantees and fund lending, which is a typical regulatory filing. Therefore, the best fit is Regulatory Filings (RNS).
2013-05-08 Chinese
102年4月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 亞諾法, with data presented in a tabular format. It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document length is short (764 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial summary or factsheet rather than a full financial report or earnings release. There is no indication of it being an announcement of a report publication or a regulatory filing. Given the concise nature and focus on key financial figures, the best fitting category is Fund Information / Factsheet (FS).
2013-05-08 Chinese
更正：初次上市公司承諾事項後續執行情形(至102年第1季止)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1299 characters) from a listed company (亞諾法生技股份有限公司) regarding the follow-up on commitments made after its initial public listing. It details the company's compliance with certain disclosure and stock holding commitments, referencing specific dates and regulatory requirements from the Taiwan Stock Exchange. The content is about the status of commitments and disclosures rather than a full financial report or detailed data. It does not contain financial statements or comprehensive financial analysis. The document is essentially a regulatory compliance update or announcement rather than a full report. Given its short length and nature, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-04-12 Chinese
初次上市公司承諾事項後續執行情形(至102年第4季止)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1296 characters) from a listed company (亞諾法生技股份有限公司) reporting on the follow-up status of commitments made after its initial public listing. It references compliance with a Taiwan Stock Exchange directive and details the company's fulfillment of various commitments related to disclosures and stock custody. The document does not contain financial statements or detailed financial data but rather a status update on regulatory commitments and corporate governance matters. It is not a full report like an Annual Report or Interim Report, nor is it a certification or legal proceeding. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-04-12 Chinese
102年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It is a disclosure of insider shareholdings and changes, typical of insider transaction or director dealing reports. There is no indication of financial statements, earnings data, or meeting materials. The document length is 3261 characters, which is relatively short and focused on insider shareholding data. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. Therefore, the document is best classified as DIRS.
2013-04-09 Chinese
102年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document text consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, general managers, and their related parties. It shows the number of shares held, changes in holdings, and other related data. The content is focused on insider shareholdings and transactions, not on financial results, management changes, or meeting materials. There is no indication of a full annual or quarterly report, earnings release, or other financial report. The document is not a brief announcement but contains substantive data on insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). Therefore, the document should be classified as DIRS.
2013-04-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.